Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal b-cell proliferation

Leukemia and Lymphoma

Volumn 20, Issue 1-2, 1995, Pages 119-124

  Monteverde, Angelo ^a   Sabattini, Elena ^b   Poggi, Simonetta ^b   Ballarè, Marco ^a   Bertoncelli, Maria Cristina ^a   de Vivo, Antonio ^b   Briskomatis, Aspasia ^b   Roncador, Giovanna ^b   Falini, Brunangelo ^c   Pileri, Stefano A ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c POLICLINICO MONTELUCE   (Italy)

Author keywords

Bone marrow; Cryoglobulinemia; HCV; Immunohistochemistry; Malignant lymphoma; Monoclonality

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW; CRYOGLOBULINEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; B-LYMPHOCYTES; BASE SEQUENCE; BIOLOGICAL MARKERS; BIOPSY; BONE MARROW; CELL DIVISION; CRYOGLOBULINEMIA; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENOME, VIRAL; HEMATOPOIETIC STEM CELLS; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS C; HIV ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TIME FACTORS;

EID: 0029561727     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199509054762     Document Type: Article

References (38)

1. Biological and clinical significance of cryoglobulins. A report of 86 cases
2. Cryoglobulinemia. A study of 39 patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability
3. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity
4. Mixed cryoglobulinemia. Clinical aspects and long-term follow-up of 40 patients
5. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma?
6. Updated Kiel classification for lymphomas
7. Aberrant immunoglobulin and c-myc gene rearrangement in patients with non malignant monoclonal cryoglobulinemia
8. Clonal B cells expansions in patients with essential mixed cryoglobulinemia
9. A cytomorphological and immunohistochemical study of bone marrow in the diagnosis of essential mixed type II cryoglobulinemia
10. Hepatitis C virus in mixed cryoglobulinemia and B cell lymphoma
11. Type II and type III mixed cryoglobulinemias, rheumatoid factors, hepatitis C virus
12. Hepatitis C virus in patients with cryoglobulinemia type II
13. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemias
14. Hepatitis C virus and mixed cryoglobulinemia
15. Infection of peripheral blood mononuclear cells by HCV in mixed cryoglobulinemia
16. A role for hepatitis C virus infection in type II mixed cryoglobulinemia
17. Single-step method of RNA isolation by acid guanidinium thyocyanate-phenol-chloroform extraction
18. Histological and immunohistological analysis of human lymphoma
19. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies
20. CD79α: a novel marker for B cell neoplasms in routinely processed tissue samples
21. 4KB5. A new monoclonal anti-B cell antibody for the routine diagnosis of lymphoid tissue biopsies
22. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen
23. Monoclonal antibody (UCHL1) that recognizes normal and neoplastic T cells in routinely fixed tissues
24. Expression of the bcl-2 oncogene protein is not specific for the 14: 18 chromosomal translocation
25. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
26. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes
27. Antigen unmasking on formalin- fixed, paraffin-embedded tissue sections
28. A Revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group
29. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas
30. Apoptosis as programmed cell death (PCD) cupio dissolvi in cell life
31. Apoptosis and disease
32. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus
33. Expression of the bcl-2 gene product in follicular lymphoma
34. Bcl-2: a repressor of lymphocyte death
35. Cloning and structural analysis of cDNA for bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
36. Regression of primary low-grade B-cell gastric lymphoma pf mucosa-associated lymphoid tissue type after eradication of
37. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
38. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to